Changes of gene expression profile in rats with diabetic cardiomyopathy after treatment of captopril evaluated by the technique of gene chip
Chen Gang,Jin Yao,Lin Li-xiang,Zhuang Wei-te,Huibin Huang,Liang Ji-xing,Fanglin Zhang,Wen Jun-ping,Liantao Li,Lin Miao,Lin Qing-ming
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.47.025
2005-01-01
Abstract:AIM: To compare the differences of gene expression in myocardial tissues between rats in the control group and interventional group, and investigate the protective role of captopril on myocardial tissue. METHODS: ① The experiment was carried out in the Department of Endocrinology, Fujian Provincial Hospital from August 2002 to December 2003. Twelve male SD rats were treated with intraperitoneal injection of streptozotocin (60 mg/kg per day) after fasted for 12 hours for 10 weeks. The blood glucose kept > 16.6 mmol/L after 5 weeks, which indicated that diabetic models were induced. ② After 10 weeks, part of the myocardial tissues were removed to examined under electron microscope, it was found that mitochondrions degenerated and contraction bands of muscle fiber formed, which indicated that models of diabetic cardiomyopathy were established. ③ Twelve rats with diabetic cardiomyopathy were randomly divided into control group (n=6) and interventional group (n=6). Rats in the interventional group were treated with oral captopril (1.5 mg/kg per day) for 15 weeks, and those in the control group were fed normally. All the rats were killed after 15 weeks, and the myocardial tissues were removed for examination of gene chip. ④ The mRNA in the control group and interventional group were labeled with Cy3-dUTP and Cy5-dUTP respectively by reverse transcription to obtain the cDNA probe. The cDNA probe was hybridized with gene expression profile chip, and the results were scanned with scanner and statistically analyzed with ImaGene3.0 software. The ratio of (Cy5/Cy3) > 2 was taken as up-regulation of gene, and Cy5/Cy3 < 1 as down-regulation of gene. RESULTS: All the 12 rats were involved in the analysis of results. ① The Cy5/Cy3 ratios of proton pump gene, which was the mitochondria proton-electron coupling and oxidative phosphorylation related gene (which reflected the energy supply of myocardial tissue), cytochrome P450, cytochrome C oxidase subunit Va, coenzyme Q1b subunit and ubiquitin-specific proteases 2 were 2.684, 2.387, 3.124, 3.213 and 3.234; The Cy5/Cy3 ratio of actin (which played an important role during myocardial contraction) was 2.277. The expressions of mitochondria proton-electron coupling and oxidative phosphorylation related gene and actin were obviously up-regulated in the interventional group. ②The Cy5/Cy3 ratio of dimethylarginine dimethylaminohydrolase (which could produce nitric oxide, lead to the increased of oxygen-derived free radicals and peroxynitrite (ONOO-) generation, and result in the damage of respiratory chain) was 0.271, and the Cy5/Cy3 ratio of integrin beta-1 (which was related with myocardial interstitial fibrosis) was 0.286. The expressions of dimethylarginine dimethylaminohydrolase gene and integrin beta-1 gene were obviously down-regulated in the interventional group.CONCLUSION: ① Captopjril can promote the generation of ATP and ensure the energy supply of damaged myocardial tissue by enhancing the expression of mitochondria proton-electron coupling and oxidative phosphorylation related gene. ② Captopjril can facilitate the contractility of damaged myocardial tissue by up-regulating the expression of actin gene. ③ Captopjril can down-regulate the expression of dimethylarginine dimethylaminohydrolase gene, reduce the generation of nitric oxide, and prevent the injury of respiratory chain. ④ Captopjril can inhibit the myocardial interstitial fibrosis through restraining the expression of integrin beta-1.